CompletedNCT00060489
Quetiapine for an acute depressive episode in bipolarity
About this title
Read the official source — NCT00060489Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 26 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00060489
- Official title
Show the full official title
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Beverly Hills · La Mesa
24 more locations
- San Diego
- Jacksonville
- Orlando
- West Palm Beach
- Winter Park
- Atlanta
- Smyrna
- Oak Brook
- Shreveport
- Clementon
- Moorestown
- New York
- Staten Island
- Raleigh
- Cincinnati
- Cleveland
- Dayton
- Columbia
- Memphis
- Austin
- Salt Lake City
- Falls Church
- Bellevue
- Kirkland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Did this study involve medication?
Yes. The study involved medication, including SEROQUEL (quetiapine fumarate) Tablets.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
